TR201917675A2 - A WOUND CARE PRODUCT - Google Patents

A WOUND CARE PRODUCT Download PDF

Info

Publication number
TR201917675A2
TR201917675A2 TR2019/17675A TR201917675A TR201917675A2 TR 201917675 A2 TR201917675 A2 TR 201917675A2 TR 2019/17675 A TR2019/17675 A TR 2019/17675A TR 201917675 A TR201917675 A TR 201917675A TR 201917675 A2 TR201917675 A2 TR 201917675A2
Authority
TR
Turkey
Prior art keywords
care product
wound care
boric acid
wound
healing
Prior art date
Application number
TR2019/17675A
Other languages
Turkish (tr)
Inventor
Kapukaya Rana
Murat Özayman Nuri̇
Original Assignee
Ulusal Bor Arastirma Enstituesue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulusal Bor Arastirma Enstituesue filed Critical Ulusal Bor Arastirma Enstituesue
Priority to TR2019/17675A priority Critical patent/TR201917675A2/en
Priority to PCT/TR2020/051083 priority patent/WO2021096469A1/en
Publication of TR201917675A2 publication Critical patent/TR201917675A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, antibakteriyel bileşenleri olarak nano borik asit partikülleri ve asidik ortamda daha verimli olan antibiyotikler taşıyan, tamamlayıcı etkileri için ek bileşenler içeren bir yara bakım ürünü ile ilgilidir. Buluşun amacı, antibakteriyel bileşen olarak, teknikte sıklıkla kullanılan ancak zararlı yan etkilere sahip olan gümüş nitrat partikülleri yerine daha biyouyumlu olan borik asit nano partiküllerinin kullanıldığı, etkili salınım süresinin uzatıldığı, böylece hücre ve akyuvar proliferasyonunun indüklenmesini arttıran, yara izi bırakmadan yara iyileştirilmesini sağlayan ve yara iyileştirme sürecini hızlandıran bir yara bakım ürünü geliştirilmesidir.The present invention relates to a wound care product that contains nano boric acid particles as its antibacterial ingredients and antibiotics that are more efficient in an acidic environment, with additional ingredients for their complementary effects. The aim of the invention is to use boric acid nanoparticles, which are more biocompatible, instead of silver nitrate particles, which are frequently used in the technique but have harmful side effects, as an antibacterial component, to extend the effective release time, thus increasing the induction of cell and white blood cell proliferation, providing wound healing without scarring, and wound healing. is the development of a wound care product that accelerates the healing process.

TR2019/17675A 2019-11-13 2019-11-13 A WOUND CARE PRODUCT TR201917675A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/17675A TR201917675A2 (en) 2019-11-13 2019-11-13 A WOUND CARE PRODUCT
PCT/TR2020/051083 WO2021096469A1 (en) 2019-11-13 2020-11-11 A wound care product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/17675A TR201917675A2 (en) 2019-11-13 2019-11-13 A WOUND CARE PRODUCT

Publications (1)

Publication Number Publication Date
TR201917675A2 true TR201917675A2 (en) 2021-05-21

Family

ID=75912268

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/17675A TR201917675A2 (en) 2019-11-13 2019-11-13 A WOUND CARE PRODUCT

Country Status (2)

Country Link
TR (1) TR201917675A2 (en)
WO (1) WO2021096469A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030216479A1 (en) * 2001-11-08 2003-11-20 Liren Huang Novel compositions comprising 2,2-Bis (4-hydroxy-3-methylphenyl) heptane and uses thereof
US20110008402A1 (en) * 2006-10-13 2011-01-13 Kane Biotech Inc. Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof
AU2009296458A1 (en) * 2008-09-26 2010-04-01 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
US9919072B2 (en) * 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
US9610282B2 (en) * 2013-03-12 2017-04-04 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process

Also Published As

Publication number Publication date
WO2021096469A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
CY1122186T1 (en) CANCER TREATMENT METHODS
EA201890201A1 (en) ANTIBACTERIAL CONNECTIONS
SA517381996B1 (en) Composition for a wound dressing
CY1125025T1 (en) 2-FORMYL-3-HYDROXYPHENYLOXIMETHYL COMPOUNDS CAPABLE OF ADJUSTING HEMOSPHERIN
CA2919397C (en) Aryl ethers as hif-2.alpha. inhibitors for the treatment of cancer
PH12016501512B1 (en) Treatment for resistant acne
CL2015002445A1 (en) Amide compounds for the treatment of hiv
MX2018015657A (en) Heterocyclic compounds as antibacte rials.
MX2018001756A (en) Substituted benzimidazoles, their preparation and their use as pharmaceuticals.
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
NI201300101A (en) MODULATION OF THE EXPRESSION OF THE SIGNAL TRANSDUCER AND TRANSCRIPTION ACTIVATOR 3 (STAT3)
TR201909626T4 (en) Composition containing ectoin or hydroxyectoin as promoting the healing of injured body tissue.
MX2015010125A (en) Pyridazinone-amides derivatives.
MX354569B (en) Cyclic amides as metap-2 inhibitors.
EA201691155A1 (en) COMBINATION INHIBITORS OF HISTONDEACETYLASE AND IMMUNOMODULATING MEDICINES
JOP20200082A1 (en) Treatment of fragile x syndrome with cannabidiol
EA201591996A1 (en) METHODS AND COMPOSITIONS FOR THE HEALING OF THE WOUNDS
BR112017023392A2 (en) antibacterial nanofibers
TR201903940T4 (en) Dressing with extended release active ingredient.
EA201590250A1 (en) CARBAMAT DERIVATIVES / UREAS
BRPI0917552B8 (en) kit for the treatment of onychomycosis
MX2022010466A (en) Combination treatment for hematological cancers.
CR20200649A (en) Tlr7 agonists
MX363604B (en) Composition comprising a combination of an acrylic polymer, a silicone copolymer and an amino acid or amino acid derivative.
MX2016006141A (en) Tooth varnish compositions and methods for their use.